Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Life Sciences And Healthcare Newsletter | June 2025

    Welcome to the June 2025 edition of our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Bridging Today And Tomorrow: Union Budget 2025-26's Vision For Progress And Innovation

    The Union Budget 2025-26 was presented by the Government of India on February 1, 2025, outlining the government's vision for accelerating economic growth, boosting investments, and ensuring inclusive
    IndiaEnergy and Natural Resources
    Lex Orbis
    Lex Orbis
  • Article

    Life Sciences And Healthcare Newsletter | August 2026

    India's pharmaceutical and healthcare regulatory landscape in August 2026 witnessed significant reforms spanning medical devices, drug safety, clinical trials, and professional registration. From stricter controls on pediatric medications to streamlined ethics review processes, these developments reshape compliance obligations and market access pathways for life sciences stakeholders.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Patenting Unpredictable Arts: Issue And Challenges

    In the context of patents, the term "unpredictable arts" refers to fields where the outcomes of experiments or innovations are not easily predictable.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Monthly Life Sciences And Healthcare Newsletter

    Welcome to the September 2024 edition of our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Checking The Pulse: Legal Developments In The Indian Healthcare And Pharma Sector

    The recent developments in the healthcare and pharma industry primarily focuses on high quality pharmacy education and equitable access to healthcare coupled with classification of certain new medical devices.
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    European Medicines Agency (EMA): Recommends Approval Of Four Medicines In Its November Meeting

    Erleada will be available as 60-mg tablets.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Regulatory Yearly Wrap 2021: Pharmaceuticals In India

    Over the past year and a half, the COVID-19 pandemic has posed a multitude of challenges and opportunities for the pharma industry.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    India-New Zealand Free Trade Agreement 2026: Tariff Benefits, Investment Opportunities And Mobility Provisions

    The India-New Zealand Free Trade Agreement (FTA) entered into force on 20 October 2026, marking a significant development in the economic relationship between the two countries. Signed in New Delhi on 27 April 2026, the agreement seeks to expand bilateral trade, improve market access, encourage investment and create new opportunities for businesses, skilled professionals and students.
    IndiaInternational Law
    King, Stubb & Kasiva
    King, Stubb & Kasiva
  • Article

    Import, Distribution And Registration Of Medical Devices In India - A Regulatory Roadmap

    The Indian Medical Device industry has shown remarkable variation in its synthesis of demand and supply.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    Checking The Pulse Recent Legal Developments In The Indian Healthcare And Pharma Sector

    Over the past couple of months, the Central Drugs Standard Control Organisation has been actively streamlining licensing and approval requirements for pharmaceutical companies...
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Lifesciences And Healthcare Newsletter | July 2025

    Welcome to the July 2025 edition of our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry and its impact on the various stakeholders.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Major Rehaul In The Customs Exemption Notifications

    The Finance Minister of India in the 2021-22 Union Budget had announced that the Government proposes to review 400 exemption notifications.
    IndiaGovernment, Public Sector
    Kochhar & Co.
    Kochhar & Co.
  • Article

    Delhi High Court Vacates Injunction, Holds 'A TO Z' Descriptive For Multivitamin Products

    Can a pharmaceutical giant's two-decade-old brand name ‘A TO Z' command exclusive rights over those three terms in the multivitamin market? And what happens when a smaller competitor enters with a composite mark containing the same alphabetical endpoints, embedded within an entirely different word?
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Patent Eligibility Of Antivirals?

    There are more than 220 viruses that are known to infect humans. Within this field of viruses, RNA viruses dominate the current list of ten global health threats.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Grants For Research & Development And Innovation In India : Part 2

    The Indian government is actively supports entrepreneurs and start-ups to promote new ideas and innovation by launching many programs and initiatives.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Yes To ‘Vanda' : Gateway To Personalised Treatment Patent!

    Personalised treatment with customised medical treatment is fast growing area of health care.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Plant Variety Protection And Farmers' Rights: A Contemporary Perspective

    Agriculture has always been the backbone of human civilization and safeguarding plant genetic resources has become a crucial endeavor in the 21st century.
    IndiaReal Estate and Construction
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Life Sciences And Healthcare Newsletter | April 2026

    India's life sciences and healthcare sector saw significant regulatory shifts in April 2026, including proposed decriminalization of minor violations, new medical device testing fees, and streamlined foreign training requirements for healthcare professionals. Courts also delivered key rulings on pharmaceutical trademark disputes, reinforcing stricter standards for drug name similarity.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Driving Fair Play: The Competition Commission Of India's Impact On The Pharmaceutical Sector

    India is known as the "pharmacy of the world" due to the low cost and high quality of its medicines, cementing its important position in the global pharmaceutical industry.
    IndiaAntitrust/Competition Law
    Shardul Amarchand Mangaldas & Co
    Shardul Amarchand Mangaldas & Co
  • Showing 401–420 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics